238 related articles for article (PubMed ID: 34511508)
1. Visualizing Muscle Sialic Acid Expression in the GNED207VTgGne-/- Cmah-/- Model of GNE Myopathy: A Comparison of Dietary and Gene Therapy Approaches.
Crowe KE; Zygmunt DA; Heller K; Rodino-Klapac L; Noguchi S; Nishino I; Martin PT
J Neuromuscul Dis; 2022; 9(1):53-71. PubMed ID: 34511508
[TBL] [Abstract][Full Text] [Related]
2. Development of Assays to Measure GNE Gene Potency and Gene Replacement in Skeletal Muscle.
Zygmunt DA; Lam P; Ashbrook A; Koczwara K; Lek A; Lek M; Martin PT
J Neuromuscul Dis; 2023; 10(5):797-812. PubMed ID: 37458043
[TBL] [Abstract][Full Text] [Related]
3. Substantial deficiency of free sialic acid in muscles of patients with GNE myopathy and in a mouse model.
Chan YM; Lee P; Jungles S; Morris G; Cadaoas J; Skrinar A; Vellard M; Kakkis E
PLoS One; 2017; 12(3):e0173261. PubMed ID: 28267778
[TBL] [Abstract][Full Text] [Related]
4. A Gne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy.
Malicdan MC; Noguchi S; Nonaka I; Hayashi YK; Nishino I
Hum Mol Genet; 2007 Nov; 16(22):2669-82. PubMed ID: 17704511
[TBL] [Abstract][Full Text] [Related]
5. Safety, pharmacokinetics and sialic acid production after oral administration of N-acetylmannosamine (ManNAc) to subjects with GNE myopathy.
Xu X; Wang AQ; Latham LL; Celeste F; Ciccone C; Malicdan MC; Goldspiel B; Terse P; Cradock J; Yang N; Yorke S; McKew JC; Gahl WA; Huizing M; Carrillo N
Mol Genet Metab; 2017 Sep; 122(1-2):126-134. PubMed ID: 28641925
[TBL] [Abstract][Full Text] [Related]
6. [GNE myopathy].
Urtizberea JA; Béhin A
Med Sci (Paris); 2015 Nov; 31 Spec No 3():20-7. PubMed ID: 26546927
[TBL] [Abstract][Full Text] [Related]
7. [Development of therapy for distal myopathy with rimmed vacuoles].
Nishino I; Malicdan MC; Noguchi S
Rinsho Shinkeigaku; 2009 Nov; 49(11):852-5. PubMed ID: 20030229
[TBL] [Abstract][Full Text] [Related]
8. Murine isoforms of UDP-GlcNAc 2-epimerase/ManNAc kinase: Secondary structures, expression profiles, and response to ManNAc therapy.
Yardeni T; Jacobs K; Niethamer TK; Ciccone C; Anikster Y; Kurochkina N; Gahl WA; Huizing M
Glycoconj J; 2013 Aug; 30(6):609-18. PubMed ID: 23266873
[TBL] [Abstract][Full Text] [Related]
9. Sialic acid deficiency is associated with oxidative stress leading to muscle atrophy and weakness in GNE myopathy.
Cho A; Christine M; Malicdan V; Miyakawa M; Nonaka I; Nishino I; Noguchi S
Hum Mol Genet; 2017 Aug; 26(16):3081-3093. PubMed ID: 28505249
[TBL] [Abstract][Full Text] [Related]
10. Non-specific accumulation of glycosphingolipids in GNE myopathy.
Patzel KA; Yardeni T; Le Poëc-Celic E; Leoyklang P; Dorward H; Alonzi DS; Kukushkin NV; Xu B; Zhang Y; Sollogoub M; Blériot Y; Gahl WA; Huizing M; Butters TD
J Inherit Metab Dis; 2014 Mar; 37(2):297-308. PubMed ID: 24136589
[TBL] [Abstract][Full Text] [Related]
11. GNE deficiency impairs Myogenesis in C2C12 cells and cannot be rescued by ManNAc supplementation.
Neu CT; Weilepp L; Bork K; Gesper A; Horstkorte R
Glycobiology; 2024 Apr; 34(3):. PubMed ID: 38224318
[TBL] [Abstract][Full Text] [Related]
12. A Gne knockout mouse expressing human V572L mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy.
Malicdan MC; Noguchi S; Nonaka I; Hayashi YK; Nishino I
Hum Mol Genet; 2007 Jan; 16(2):115-28. PubMed ID: 17164266
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of
Peters E; Selke P; Bork K; Horstkorte R; Gesper A
Front Biosci (Landmark Ed); 2023 Nov; 28(11):300. PubMed ID: 38062838
[TBL] [Abstract][Full Text] [Related]
14. Oral monosaccharide therapies to reverse renal and muscle hyposialylation in a mouse model of GNE myopathy.
Niethamer TK; Yardeni T; Leoyklang P; Ciccone C; Astiz-Martinez A; Jacobs K; Dorward HM; Zerfas PM; Gahl WA; Huizing M
Mol Genet Metab; 2012 Dec; 107(4):748-55. PubMed ID: 23122659
[TBL] [Abstract][Full Text] [Related]
15. GNE myopathy: current update and future therapy.
Nishino I; Carrillo-Carrasco N; Argov Z
J Neurol Neurosurg Psychiatry; 2015 Apr; 86(4):385-92. PubMed ID: 25002140
[TBL] [Abstract][Full Text] [Related]
16. Role of HSP70 chaperone in protein aggregate phenomenon of GNE mutant cells: Therapeutic lead for GNE Myopathy.
Yadav R; Devi SS; Oswalia J; Ramalingam S; Arya R
Int J Biochem Cell Biol; 2022 Aug; 149():106258. PubMed ID: 35777599
[TBL] [Abstract][Full Text] [Related]
17. [Animal model of distal myopathy with rimmed vacuoles/hereditary inclusion body myopathy and preclinical trial with sugar compounds].
Noguchi S; Malicdan MC; Nishino I
Brain Nerve; 2010 Jun; 62(6):601-7. PubMed ID: 20548120
[TBL] [Abstract][Full Text] [Related]
18. Aceneuramic Acid Extended Release Administration Maintains Upper Limb Muscle Strength in a 48-week Study of Subjects with GNE Myopathy: Results from a Phase 2, Randomized, Controlled Study.
Argov Z; Caraco Y; Lau H; Pestronk A; Shieh PB; Skrinar A; Koutsoukos T; Ahmed R; Martinisi J; Kakkis E
J Neuromuscul Dis; 2016 Mar; 3(1):49-66. PubMed ID: 27854209
[TBL] [Abstract][Full Text] [Related]
19. Correction of the Middle Eastern M712T mutation causing GNE myopathy by trans-splicing.
Tal-Goldberg T; Lorain S; Mitrani-Rosenbaum S
Neuromolecular Med; 2014 Jun; 16(2):322-31. PubMed ID: 24264357
[TBL] [Abstract][Full Text] [Related]
20. Sialyllactose ameliorates myopathic phenotypes in symptomatic GNE myopathy model mice.
Yonekawa T; Malicdan MC; Cho A; Hayashi YK; Nonaka I; Mine T; Yamamoto T; Nishino I; Noguchi S
Brain; 2014 Oct; 137(Pt 10):2670-9. PubMed ID: 25062695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
